U-Blot® Research Grade Anti-Human CD227/MUC1 (SPmAb2.1)Cat. No. WA1456Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD227/MUC1 (SPmAb2.1)Cat. No. WA1456
U-Blot® Research Grade Anti-Human CD227/MUC1 (R1549)Cat. No. WA1455
U-Blot® Research Grade Anti-Human CD227/MUC1 (huDMB5F3)Cat. No. WA1454
U-Blot® Research Grade Anti-Human CD227/MUC1 (BTH1704)Cat. No. WA1453
U-Blot® Research Grade Anti-Human CD227/MUC1 (AR20.5)Cat. No. WA1452
U-Blot® Research Grade Anti-Human CD226/DNAM-1 Antibody (lilly01)Cat. No. WA1451
U-Blot® Research Grade Anti-Human CD226/DNAM-1 Antibody (COMPASS01)Cat. No. WA1450
U-Blot® Research Grade Anti-Human CD223/LAG3 Antibody (BI 754111)Cat. No. WA1449
U-Blot® Research Grade Anti-Human CD223/LAG3 (Sym022)Cat. No. WA1448
U-Blot® Research Grade Anti-Human CD223/LAG3 (MLB102)Cat. No. WA1447
U-Blot® Research Grade Anti-Human CD223/LAG3 (KL-A289)Cat. No. WA1446
U-Blot® Research Grade Anti-Human CD223/LAG3 (INCAGN2385)Cat. No. WA1445